Garrod, A. The incidence of alkaptonuria. A study in chemical individuality. Lancet 160, 1616–1620 (1902).
Fernândez-Canon, J. M. et al. The molecular basis of alkaptonuria. Nat. Genet. 14, 19–24 (1996). The authors describe the cloning of the human HGD gene and demonstrate for the first time, to our knowledge, that it harbours missense variants that co-segregate with the disease in the families.
Vilboux, T. et al. Mutation spectrum of homogentisic acid oxidase (HGD) in alkaptonuria. Hum. Mutat. 30, 1611–1619 (2009).
Article CAS PubMed PubMed Central Google Scholar
Zannoni, V. G., Seegmiller, J. E. & La Du, B. N. Nature of the defect in alcaptonuria. Nature 193, 952–953 (1962).
Article CAS PubMed ADS Google Scholar
Phornphutkul, C. et al. Natural history of alkaptonuria. N. Engl. J. Med. 347, 2111–2121 (2002). This is the reference study for the definition of the natural history of AKU.
Article CAS PubMed Google Scholar
Gallagher, J. A., Ranganath, L. R. & Zatkova, A. in Brenner’s Encyclopedia of Genetics 2nd edn (eds Malay, S. & Hughes, K.) 71–75 (Elsevier, 2013).
Chow, W. Y. et al. Pigmentation chemistry and radical-based collagen degradation in alkaptonuria and osteoarthritic cartilage. Angew. Chem. Int. Ed. 59, 11937–11942 (2020). The authors propose that collagen degradation in AKU occurs via transient glycyl radicals, and this process is enhanced due to the redox environment generated by pigmentation.
Bernini, A. et al. A molecular spectroscopy approach for the investigation of early phase ochronotic pigment development in alkaptonuria. Sci. Rep. 11, 22562 (2021).
Article CAS PubMed PubMed Central ADS Google Scholar
Barrios, P. C. & Font, R. L. Pigmented conjunctival lesions as initial manifestation of ochronosis. Arch. Ophthalmol. 122, 1060–1063 (2004).
Ranganath, L. R. et al. Reversal of ochronotic pigmentation in alkaptonuria following nitisinone therapy: analysis of data from the United Kingdom National Alkaptonuria Centre. JIMD Rep. 55, 75–87 (2020).
Article PubMed PubMed Central Google Scholar
Dewan, K., MacDonald, C. B. & Shires, C. B. Blue man: ochronosis in otolaryngology. Clin. Case Rep. 10, e05717 (2022).
Article PubMed PubMed Central Google Scholar
Mannoni, A. et al. Ochronosis, and ochronotic arthropathy. Semin. Arthritis Rheum. 33, 239–248 (2004).
Millucci, L. et al. Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient. Mediators Inflamm. 2014, 258471 (2014).
Article PubMed PubMed Central Google Scholar
Millucci, L. et al. Diagnosis of secondary amyloidosis in alkaptonuria. Diagn. Pathol. 9, 185 (2014).
Article PubMed PubMed Central Google Scholar
Millucci, L. et al. Secondary amyloidosis in an alkaptonuric aortic valve. Int. J. Cardiol. 172, e121–e123 (2014).
Article PubMed PubMed Central Google Scholar
Křížek, V. Urolithiasis and prostatolithiasis in alcaptonuria with ochronosis. Int. Urol. Nephrol. 3, 245–250 (1971).
Introne, W. J. et al. Exacerbation of the ochronosis of alkaptonuria due to renal insufficiency and improvement after renal transplantation. Mol. Genet. Metab. 77, 136–142 (2022).
Lazaro, J. S., Lutz, R. & Deirmengian, G. K. Bilateral patellar tendon rupture following total knee arthroplasty in a patient with alkaptonuria: a case report. Cureus 15, e38597 (2023).
PubMed PubMed Central Google Scholar
Zatkova, A., Ranganath, L. & Kadasi, L. Alkaptonuria: current perspectives. Appl. Clin. Genet. 13, 37–47 (2020).
Article CAS PubMed PubMed Central Google Scholar
Ranganath, L. R. & Cox, T. F. Natural history of alkaptonuria revisited: analyses based on scoring systems. J. Inherit. Metab. Dis. 34, 1141–1151 (2011). The authors applied advanced statistical methods to describe the natural history by quantitating the features of AKU, revealing distinct phases of the disease: a pre-ochronotic phase and an ochronotic phase.
Introne, W. J., Perry, M. & Chen, M. Alkaptonuria. GeneReviews [Internet] www.ncbi.nlm.nih.gov/books/NBK1454/ (updated 10 June 2021).
Milch, R. A. Studies of alcaptonuria: inheritance of 47 cases in eight highly inter-related Dominican kindreds. Am. J. Hum. Genet. 12, 76–85 (1960).
CAS PubMed PubMed Central Google Scholar
Al-Sbou, M., Mwafi, N. & Lubad, M. A. Identification of forty cases with alkaptonuria in one village in Jordan. Rheumatol. Int. 32, 3737–3740 (2012).
Al-Sbou, M. & Mwafi, N. Nine cases of alkaptonuria in one family in southern Jordan. Rheumatol. Int. 32, 621–625 (2012).
Sakthivel, S. et al. Mutation screening of the HGD gene identifies a novel alkaptonuria mutation with significant founder effect and high prevalence. Ann. Hum. Genet. 78, 155–164 (2014).
Article CAS PubMed Google Scholar
Srsen, S. & Varga, F. Screening for alkaptonuria in the newborn in Slovakia. Lancet 2, 576 (1978).
Article CAS PubMed Google Scholar
Zatková, A. et al. High frequency of alkaptonuria in Slovakia: evidence for the appearance of multiple mutations in HGO involving different mutational hot spots. Am. J. Hum. Genet. 67, 1333–1339 (2000).
Article PubMed PubMed Central Google Scholar
Zatkova, A. An update on molecular genetics of alkaptonuria (AKU). J. Inherit. Metab. Dis. 34, 1127–1136 (2011).
Zatkova, A. et al. Identification of 11 novel homogentisate 1,2 dioxygenase variants in alkaptonuria patients and establishment of a novel LOVD-based HGD mutation database. JIMD Rep. 4, 55–65 (2012). The authors report on the establishment of a disease-specific HGD mutation database that summarizes all AKU gene variants identified so far in patients with AKU. This database is still active and regularly updated.
Soltysova, A., Kuzin, A., Samarkina, E. & Zatkova, A. Alkaptonuria in Russia. Eur. J. Hum. Genet. 30, 237–242 (2022).
Article CAS PubMed Google Scholar
Cox, T. F. & Ranganath, L. A quantitative assessment of alkaptonuria: testing the reliability of two disease severity scoring systems. J. Inherit. Metab. Dis. 34, 1153–1162 (2011).
Article CAS PubMed Google Scholar
Perry, M. B., Suwannarat, P., Furst, G. P., Gahl, W. A. & Gerber, L. H. Musculoskeletal findings and disability in alkaptonuria. J. Rheumatol. 33, 2280–2285 (2006).
Ranganath, L. R., Khedr, M., Vinjamuri, S. & Gallagher, J. A. Frequency, diagnosis, pathogenesis and management of osteoporosis in alkaptonuria: data analysis from the UK National Alkaptonuria Centre. Osteoporos. Int. 32, 927–938 (2021).
Article CAS PubMed Google Scholar
Ranganath, L. R. et al. Homogentisic acid is not only eliminated by glomerular filtration and tubular secretion but also produced in the kidney in alkaptonuria. J. Inherit. Metab. Dis. 43, 737–747 (2020).
Article CAS PubMed Google Scholar
Mistry, J. B., Bukhari, M. & Taylor, A. M. Alkaptonuria. Rare Dis. 1, e27475 (2013).
Article PubMed PubMed Central Google Scholar
Kitahara, Y., Kaku, N., Tagomori, H. & Tsumura, H. Alkaptonuria with rapidly destructive arthropathy of the hip: a case report and literature review. Acta Orthop. Traumatol. Turc. 55, 563–568 (2021).
Ranganath, L. R., Khedr, M., Mistry, A., Vinjamuri, S. & Gallagher, J. A. Treatment of osteoporotic fractures in alkaptonuria by teriparatide stimulates bone formation and decreases fracture rate – a report of two cases. Bone Rep. 15, 101151 (2021).
Article CAS PubMed PubMed Central Google Scholar
Gómez-Lechón Quirós, L. et al. Family history of ochronotic arthropathy. Rheumatol. Int. 41, 1869–1874 (2021).
Taylor, A. M. et al. The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria. Arthritis Rheum. 63, 3887–3896 (2011).
Article CAS PubMed Google Scholar
Taylor, A. M. et al. Identification of trabecular excrescences, novel microanatomical structures, present in bone in osteoarthropathies. Eur. Cell Mater. 23, 300–309 (2012).
Article CAS PubMed Google Scholar
Ebrahim, I. C., Hoang, T. D., Vietor, N. O., Schacht, J. P. & Shakir, M. K. M. Dilemmas in the diagnosis and management of osteoporosis in a patient with alkaptonuria: successful treatment with teriparatide. Clin. Case Rep. 10, e6729 (2022).
留言 (0)